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Background: We have found that community health workers (CHWs) with appropriate training are able to
accurately identify people at high cardiovascular disease (CVD) risk in the community who would benefit from
the introduction of preventative management, in Bangladesh, Guatemala, Mexico, and South Africa. This
paper examines the attendance pattern for those individuals who were so identified and referred to a health care
facility for further assessment and management.
Design: Patient records from the health centres in each site were reviewed for data on diagnoses made and
treatment commenced. Reasons for non-attendance were sought from participants who had not attended
after being referred. Qualitative data were collected from study coordinators regarding their experiences
in obtaining the records and conducting the record reviews. The perspectives of CHWs and community
members, who were screened, were also obtained.
Results: Thirty-seven percent (96/263) of those referred attended follow-up: 36 of 52 (69%) were urgent and
60 of 211 (28.4%) were non-urgent referrals. A diagnosis of hypertension (HTN) was made in 69% of urgent
referrals and 37% of non-urgent referrals with treatment instituted in all cases. Reasons for non-attendance
included limited self-perception of risk, associated costs, health system obstacles, and lack of trust in CHWs
to conduct CVD risk assessments and to refer community members into the health system.
Conclusions: The existing barriers to referral in the health care systems negatively impact the gains to be had through
screening by training CHWs in the use of a simple risk assessment tool. The new diagnoses of HTN and com-
mencement on treatment in those that attended referrals underscores the value of having persons at the highest risk
identified in the community setting and referred to a clinic for further evaluation and treatment.
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L
ow- and middle-income countries (LMIC) carry
the highest global burden of cardiovascular dis-
eases (CVD) and can ill-afford the considerable
attendant health costs. Consequently, there is great need
to establish affordable primary prevention strategies (13).
One such strategy is the use of a risk assessment tool that
can accurately identify people at high risk of CVD who
will benefit most from referral for definitive diagnoses
and appropriate treatment. Risk is usually determined by
calculating a risk score based on assessing a combination
of risk factors, including, age, gender, tobacco use, blood
pressure levels, blood cholesterol levels, diabetes or family
history of CVD (46). A non-laboratory-based CVD risk
assessment model has been developed in response to the
costs and inconvenience of the laboratory-based scores.
This simplified model substitutes blood lipid levels with
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body mass index to calculate the absolute CVD risk score,
thus making CVD risk screening far more feasible and
potentially cost effective in both high- and low-resource
settings (4). With the current global shortages of skilled
health workers, sharing basic health promotion and dis-
ease prevention tasks with community health workers
(CHWs) is gaining increasing traction and plays a crucial
role in improving access to health services in under-
resourced settings (5). In addition, a community-based
risk assessment model has the ability to reach a larger
portion of the population than a facility-based model
and has been identified as key in successfully reducing
and managing the rising incidence of CVD (6, 7). Early
determination of CVD risk does not necessarily lead to
better health outcomes unless those identified to be at
risk modify their risk factors over time (6). Appropriate
referral into the health system and follow-up over time
is a crucial step in ensuring the success of this primary
prevention strategy. High rates of attrition between CVD
screening and follow-up at health facilities is common
and even when those at risk are formally diagnosed and
started on treatment, compliance with lifestyle changes
or medication can be challenging due to the numerous
financial and sociocultural barriers faced by individuals
in developing countries (7, 8).
As part of a multinational study in which screening
for CVD risk was conducted by CHWs in community
settings, CHWs also provided those individuals identified
to be at high risk with referral letters to primary health
facilities for formal assessment and management (9). One
of the aims of this study was to examine the immediate
outcome, in terms of attendance, for high-risk individuals
who were referred within existing referral pathways by a
CHW to a health care facility for further assessment and
management.
Methods
The study was conducted in the four LMIC country sites
of Bangladesh, Guatemala, Mexico, and South Africa.
The definition of LMIC is that used by the World Health
Organization (10) and all four participating sites are part
of a network of centres of excellence for chronic diseases
which seeks to identify problems and solutions across
populations where the burden of diseases is high but the
resources to address them are low.
Between 8 and 15 CHWs from each site were recruited
and trained to calculate a CVD risk score using a non-
laboratory-based CVD risk assessment tool. The tool uses
age, sex, current smoking status, diabetes status, measured
systolic blood pressure, weight and height, and a decision
support chart to determine a risk score. A risk score
of either B10% (low risk), 1020% (lowmoderate risk),
2030% (moderate risk), 3040% (moderatehigh risk),
or 40% (high risk) is thus calculated, where for instance,
a risk score of 40% would mean that an individual had
a 40% chance of having a fatal or non-fatal cardiovas-
cular even in the next 5 years.
After demonstrating their proficiency in the above-
mentioned method, each CHW opportunistically screened
a minimum of 100 community members over a 4- to
6-week period in three settings at all four sites: individual
homes, at community events, or at self-help groups (11).
To be eligible for inclusion, community members had to
be between the ages of 35 and 74 years with no reported
past history of hypertension (HTN), diabetes (DM), or
CVD (i.e. stroke, myocardial infarction, or angina) as
these individuals were assumed to have already been part
of the health system. Study participants were representa-
tive of the urban, rural, or peri-urban poor populations
for each participating countries.
Two groups of participants were eligible for referral at
the time of screening. 1) Urgent referrals to the closest
clinic for immediate evaluation by a health professional
were made for participants found to have a mean systolic
blood pressure of 180 mmHg. 2) Non-urgent referrals
were provided to participants with a calculated risk score
of greater than 20%, and they were advised to present
within 2 weeks of screening for further assessment. The
referral pathways varied at each of the four country sites.
In Bangladesh, dedicated study doctors were recruited
to be available to assess referred community members.
In Guatemala, a specific day of the week was allocated in
the main primary health care centre of the community
to receive referred participants. In Mexico, non-urgent
referrals were made to participating health centres while
urgent referrals were accepted by the general hospital.
In South Africa, both urgent and non-urgent referrals
were made to participating primary clinics and the field
coordinator provided transport for the urgent referrals
during the run-in period where four persons were found to
have mean systolic blood pressure readings 180 mmHg,
requiring clinical intervention. Official cooperation had
been set up prior to the commencement of screenings.
These ranged from three to four clinics per site. At the
start of the study, permission was obtained from the
relevant health authorities for study coordinators to visit
the designated clinics in order to review available clinic
records for the screened participants to whom a referral
letter was provided.
The field team in each site accessed patient records
at their respective health centres within 6 months of the
initial referral. Charts were reviewed to determine whether
the visit occurred, what diagnoses were made, and what
treatment was initiated. Due to the suboptimal scheduling
and attending of the referral visits, study coordinators
were asked to implement a limited telephone contact
protocol to try to reach individual participants for a total
of three attempts. Each attempt had to be made at a
different time of day: morning, afternoon, and evening.
If the participants could not be reached using this
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protocol, the study coordinator noted that the referral
visit attendance was ‘unknown’. Due to the resource cons-
traints on the study, further qualitative inquiry from the
participants was not possible. In addition participants
who had been referred but who had not attended were
contacted by the research teams to ascertain their reasons
for not presenting to the respective health centres for
formal evaluation and further management.
Study coordinators kept detailed notes on their find-
ings regarding the review of medical records to determine
whether referral visits were scheduled and attended. Manual
coding for recurrent and divergent themes of the notes were
performed by study coordinators and site investigators.
Summaries of these notes were reviewed by site investigators
prior to being provided to the data coordinating centre in
English to allow for comparison across sites.
We conducted Pearson Chi-square tests of homogeneity
to identify any patterns with respect to verifying the
occurrence of referral visits, any resulting diagnoses, and
any treatment provided. All data were de-identified prior
to data entry and analyses. Quantitative analyses were
performed using Stata 12 (12) and SAS 9.4 (13) statistical
packages.
The study protocol was approved by the individual site
ethics and institutional review boards (IRB), as well as
the NHLBI. CHWs were trained to explain the consent
forms and to answer any questions related to its contents
prior to obtaining informed consent.
Results
Quantitative results
Amongst the 4,383 community members who agreed to
participate in this study, 247 were ineligible and 35 partici-
pants did not complete the screening process. As a result,
4,101 participants were eligible for screening or referral, of
which 1,016 (24.8%) were men (range: 20.0% in Guatemala,
to 28.9% in South Africa) and 3,077 (75.2%) were women
(range: 71.1% in South Africa, to 80.0% in Guatemala).
During screening, 52 (1.3%) were found to have an average
systolic blood pressure 180 mmHg and were provided
with a same-day, urgent referral letter for assessment at
the nearest clinic. The remaining eligible participants
(n4,049) had a CVD risk score calculated by the CHWs
and were stratified into one of five risk categories from low
to high (Fig. 1). The distribution of the CVD risk was found
to be: 77.4% low risk, 17.4% low to moderate risk, 3.7% with
moderate risk, 1.1% moderatehigh risk and 0.2% high risk.
The risk distribution across sites was similar in all five risk
categories. Participants who were at lowest risk for CVD
(Risk Score from 0 to 20%) ranged from 93% (South Africa)
to 97% (Mexico) of the eligible, screened population,
with a mean of 95%. Those at moderate risk who were
eligible for referral (Risk Score from 21 to 40%) ranged
from 3% (Guatemala and Mexico) to 7% (South Africa),
with a mean of 5%. The proportion of persons who were
eligible for urgent referral by being at highest risk (Risk
Score 40%) ranged from 0% (Guatemala) to 0.3%
(South Africa).
Overall 263 of 4,101 (6.4%) participants were referred.
Of these 52 (19.8%) were urgent and 211 (80.2%) non-
urgent referrals (Fig. 2). Amongst all the referrals, we
were able to verify that 96 (36.5%) scheduled and
attended a visit at the local clinic, of which 36 of 52
(69%) were by those given urgent referrals and 60 of 211
(28.4%) by those given non-urgent referrals (Fig. 3).
Those with urgent referrals scheduled and attended a visit
at the clinic at a greater level (69%) compared to those
who were provided with a non-urgent referral (28%)
(pB0.001; Pearson x225.6; 1 df). Additionally, at
all these verified visits, 69.4% of the urgently referred
persons were likely to receive a diagnosis of HTN,
compared to the 37% of non-urgently referred persons
(pB0.008; Pearson x27.1; 1 df). HTN was the only
diagnosis received by all those confirmed to have
attended referral visits and 100% of those diagnosed
received a prescription for anti-hypertensive medication.
Qualitative findings
A number of themes emerged from assessing the experi-
ences of both the CHWs and the community members
being screened for CVD that provide insights into the low
attendance following referral as well as into the challen-
ges in verifying follow-up data. The findings were remark-
ably consistent across the four country sites (Table 1).
Discussion
These findings demonstrate that when people are oppor-
tunistically screened in the community by CHWs and
identified as being at a high risk of developing CVD, only
a minority (37%) schedule and attend the local health
facility after being referred for further evaluation. Where
referral visits were verified, there was significantly more
follow-through on the part of participants who were
provided with urgent referrals (69%) compared to those
provided with non-urgent referrals (28%). In addition, a
new diagnosis of HTN was made in over two thirds (69%)
of urgent referrals and 37% of non-urgent referrals; with
100% of these cases having treatment initiated.
Higher attendance rates from CHW-initiated referrals
have been described in studies conducted in other LMICs
with attendance rates ranging from 58 to 93% (1216).
These primarily involved CHWs identifying and referring
ailing paediatric patients from a community setting into
the health system. Predictors of referral compliance in-
cluded being clinically sick and receiving reminder visits
from CHWs (13). In a study done in Ecuador evaluating
referral adherence using the Integrated Management of
Childhood Illness (IMCI) approach in the community,
the attendance rate was found to be 58%. In this study,
Referral outcomes of individuals identified at high risk of CVD
Citation: Glob Health Action 2015, 8: 26318 - http://dx.doi.org/10.3402/gha.v8.26318 3
(page number not for citation purpose)
two factors relating to CHW actions, in providing a
referral letter and in making urgent referral, reduced the
risk of not attending from 96% to 19%. In Uganda the
difference in urgent and non-urgent referral attendance
rates within a community-based malaria treatment pro-
gramme was found to be less than 10% (93% for urgent
referrals and 84% for non-urgent referrals) with a high
overall attendance rate of 87% (12). In a randomised
control trial done in a low-income urban community
site in the United States, the referral attendance rates of
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Fig. 1. Overview of study participants.
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individuals identified with high blood pressure were com-
pared using enhanced CHW-supported referrals with usual
referrals. The attendance rate for the enhanced CHW
referral intervention was 65.1% compared to 46.7% in the
usual-care group (17). While these findings suggest that
higher attendance rates of CHW-initiated referrals are
possible, it may require additional CHW referral support
(such as providing reminders and follow-up visits) in ins-
tances when asymptomatic patients are targeted com-
pared to those that are more acutely unwell.
The qualitative data that were consistent across all
settings expands on the factors that inhibited scheduling
and attending visits across the four sites and include the
associated costs, opportunity costs, health system barriers,
and paradigms of risk perception. The latter being a parti-
cularly important consideration when designing interven-
tions that aim to bring asymptomatic patients into the
health system.
Furthermore, the disputed authority of CHWs to con-
duct CVD risk assessments and to refer community
members into the health system was also identified as
an obstacle. CHWs are seen as a threat by existing health
professionals and are not accepted as being adequately
qualified to refer persons at high risk for further assess-
ment at the health clinics. While this may be the case
when CHWs refer asymptomatic patients, there is no
Fig. 2. Number and type of referral by country.
*In Guatemala, no subjects had an average SBP180 mmHg which is the requirement for urgent referral.
Fig. 3. Attendance outcome by country.
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evidence of resistance to CHW referrals when sick patients
are identified in the community and referred into the
health system (13, 15).
A number of behaviour theories have been developed
to explain the failure of people to participate in health-
screening activities. The Health Belief Model is one
example, which suggests that people’s beliefs about health
problems, perceived benefits and barriers to action, and
self-efficacy explain engagement (or lack of engagement)
in health-promoting behaviour and where a cue to action is
also required to trigger the health-promoting behaviour
(18). Our findings suggest that providing a referral that
is urgent is more likely to lead to a health-promoting
behaviour (in attending the referral) and may therefore be
a more effective cue to action, compared to providing a
non-urgent referral to someone that is asymptomatic.
A limitation of this study was the inability to confirm
attendance after referral in the majority of cases, due to
inherent health system challenges such as lack of access
to records, inability to find records, and incomplete re-
cords as well as challenges in directly contacting mobile
community members. This was a study done in real-world
settings where our findings underscore that current pri-
mary care practices in these settings did not allow for
efficient tracking of patients who are referred. For this
reason, it is difficult to comment on the different rates
of attendance across the four settings. The design choice
to not alter existing referral pathways beyond what we
did was intended to provide evidence for the anecdotal
impression that existing referral pathways at the sites
were not effective in ensuring that those identified at risk
of CVD are adequately bought into the health system.
Table 1. Reasons for low attendance following referral and challenges identified in verifying visits at clinics
Theme Description
Reasons
Risk perception A common problem across all four sites was the disbelief of the individuals screened that
their CVD level of risk was high and that a referral visit with a health professional was
necessary. The lack of symptoms made the referral seem unnecessary.
Influence of traditional versus Western
medical care
Many individuals deferred to their beliefs in traditional medicine over the screening
assessment, which reduced the rate of follow-up at Western medical facilities.
Lack of trust in the role of CHWs in screening
for CVD
Individuals were unaccustomed to CHWs performing CVD risk assessment as well as
making referrals to health facilities. Their perceptions of the roles of CHWs were limited
to dispensing of medication and/or provision of health education.
Acceptance of referrals made by CHWs by
health professionals
The authority of the CHW to refer persons at risk to the clinics was disputed at almost all
the sites. CHWs were not regarded as qualified to make referrals of the type provided in
the study, by both clinical and clerical staff at the clinics. The ability of the CHWs to assess
CVD risk was also perceived as a threat by the health professionals.
Fear of reprimand and the lack of support
from health facilities.
Individuals did not wish to be ‘scolded’ by health personnel for not seeking help sooner
despite not knowing they were at risk of CVD.
Communication barriers Individuals that spoke different languages to the health professionals at the referring
facilities anticipated difficulties in communicating and did not see the value in attending
the referral visit.
Opportunity cost of attending health facilities Individuals that were employed identified the opportunity costs related to attending clinics
for the referral visits as being inhibitory.
Cost of medication Individuals referred for formal diagnosis and treatment were not always guaranteed free
access to medication. In Guatemala, for instance, referred participants were discouraged
from attending due to the incurred expense of accessing medicine.
Travel cost of attending health facilities The travel costs associated with attending a referral visit prevented some individuals from
attending the referral visit.
Challenges
Access to health facilities and patient
medical records
While the individual sites had arranged for referral visits to take place at individual health
centres with clinic directors, this permission did not always translate to administrators at
various levels at these clinics accommodating the study coordinators’ attempts to verify
the visits.
Patient health records could not be found In two of the countries, patient records could not be found due to a lack of systematic
re-filing of folders. Single paper records were often misplaced between different
programs of care.
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There are a number of avenues for future research. One
is in understanding how community members perceive
risk and why they choose to attend clinic when identified
at high risk when referred by CHWs. In addition, work is
also required in testing new models of referral pathways,
such as linking CHWs to nurses or larger care teams, or
creating dedicated appointment slots at health centres for
individuals at high risk of CVD.
Conclusion
The existing barriers to referral in the health care systems
negatively impact the gains to be had through screening
by training CHWs in the use of a simple risk assessment
tool. The new diagnoses of HTN and commencement on
treatment in those that attended referrals underscores the
value of having persons at the highest risk identified in
the community setting and referred to a clinic for further
evaluation and treatment. If the referral mechanisms
and medical record access can be improved, these would
result in even further gains in diagnoses and treatment
resulting from CHWs conducting opportunistic community-
based screenings.
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